{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:35:19Z","timestamp":1776285319828,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671235"],"award-info":[{"award-number":["81671235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jocn.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T10:39:06Z","timestamp":1556879946000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement"],"prefix":"10.1016","volume":"65","author":[{"given":"Meirong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingjun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.04.002_b0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2019.04.002_b0010","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2019.04.002_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jneuroim.2014.07.006","article-title":"Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies","volume":"274","author":"Suzuki","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2019.04.002_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jocn.2019.04.002_b0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2019.04.002_b0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.jocn.2019.04.002_b0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jocn.2019.04.002_b0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromusc Disord NMD"},{"key":"10.1016\/j.jocn.2019.04.002_b0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2019.04.002_b0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28\u201330 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromusc Disord NMD"},{"issue":"Suppl. 2","key":"10.1016\/j.jocn.2019.04.002_b0055","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies","volume":"71","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocn.2019.04.002_b0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New Engl J Med"},{"issue":"595\u2013628","key":"10.1016\/j.jocn.2019.04.002_b0065","first-page":"vii","article-title":"Idiopathic inflammatory myopathies","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jocn.2019.04.002_b0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2019.04.002_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2016.00064","article-title":"Idiopathic inflammatory myopathies: clinical approach and management","volume":"7","author":"Malik","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2019.04.002_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jocn.2019.04.002_b0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2019.04.002_b0090","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1242\/jcs.070490","article-title":"New insights into the role of mitochondria in aging: mitochondrial dynamics and more","volume":"123","author":"Seo","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jocn.2019.04.002_b0095","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2019.04.002_b0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-394625-6.00004-0","article-title":"Mitochondrial dynamics in aging and disease","volume":"127","author":"Bereiter-Hahn","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jocn.2019.04.002_b0105","first-page":"1387","article-title":"The role of mitochondrial dysfunction in age-related diseases","volume":"1847","author":"Lane","year":"2015","journal-title":"BBA"},{"key":"10.1016\/j.jocn.2019.04.002_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00709-013-0515-x","article-title":"Do we age because we have mitochondria?","volume":"251","author":"Bereiter-Hahn","year":"2014","journal-title":"Protoplasma"},{"key":"10.1016\/j.jocn.2019.04.002_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/238463","article-title":"Mitochondrial aging and age-related dysfunction of mitochondria","volume":"2014","author":"Chistiakov","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jocn.2019.04.002_b0120","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00439-014-1458-9","article-title":"Mitochondrial DNA copy number in peripheral blood cells declines with age and is associated with general health among elderly","volume":"133","author":"Mengel-From","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.jocn.2019.04.002_b0125","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00018-017-2619-5","article-title":"Mitochondrial bioenergetics decay in aging: beneficial effect of melatonin","volume":"74","author":"Paradies","year":"2017","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10.1016\/j.jocn.2019.04.002_b0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00439-011-1057-y","article-title":"Mitochondrial DNA and inflammatory diseases","volume":"131","author":"Escames","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.jocn.2019.04.002_b0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0b013e32833f108a","article-title":"Mitochondrial pathology in immune and inflammatory myopathies","volume":"22","author":"Varadhachary","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jocn.2019.04.002_b0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.freeradbiomed.2005.10.054","article-title":"The role of oxidative stress in adult critical care","volume":"40","author":"Crimi","year":"2006","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.jocn.2019.04.002_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-017-1731-9","article-title":"IFN-beta-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis","author":"Meyer","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2019.04.002_b0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jocn.2019.04.002_b0155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","article-title":"Mitochondria in the regulation of innate and adaptive immunity","volume":"42","author":"Weinberg","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jocn.2019.04.002_b0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2015.06.009","article-title":"Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis","volume":"285","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2019.04.002_b0165","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jocn.2019.04.002_b0170","article-title":"Inflammatory myopathy associated with antimitochondrial antibodies: a distinct phenotype with cardiac involvement","author":"Albayda","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jocn.2019.04.002_b0175","article-title":"Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies","author":"Mauhin","year":"2017","journal-title":"Joint Bone Spine: revue du rhumatisme"},{"key":"10.1016\/j.jocn.2019.04.002_b0180","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2019.04.002_b0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","article-title":"The presentation and diagnosis of 100 patients with primary biliary cirrhosis","volume":"289","author":"Sherlock","year":"1973","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jocn.2019.04.002_b0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/03009742.2016.1258730","article-title":"What is the third serological marker associated with immune-mediated necrotizing myopathy?","volume":"46","author":"Tanaka","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jocn.2019.04.002_b0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.nmd.2015.04.013","article-title":"Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients","volume":"25","author":"Johnson","year":"2015","journal-title":"Neuromusc Disord NMD"},{"key":"10.1016\/j.jocn.2019.04.002_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.berh.2016.04.007","article-title":"Idiopathic inflammatory myositis","volume":"30","author":"Tieu","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jocn.2019.04.002_b0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/mus.22261","article-title":"Granulomatous myositis associated with brucellosis: a case report and literature review","volume":"45","author":"Kojan","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2019.04.002_b0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0031-9384(95)02155-8","article-title":"Predominant right leg dysfunction without asymmetric muscle inflammation in CD1 Swiss mice with coxsackievirus B1-induced myositis","volume":"59","author":"Jongen","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jocn.2019.04.002_b0215","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e328324e700","article-title":"Exercise effects in patients with adult idiopathic inflammatory myopathies","volume":"21","author":"Alexanderson","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jocn.2019.04.002_b0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/joim.12481","article-title":"Physical exercise as a treatment for adult and juvenile myositis","volume":"280","author":"Alexanderson","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.jocn.2019.04.002_b0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0b013e32834f19f5","article-title":"Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies","volume":"24","author":"Alexanderson","year":"2012","journal-title":"Curr Opin Rheumatol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818309329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818309329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:08:48Z","timestamp":1559938128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818309329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":45,"alternative-id":["S0967586818309329"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.04.002","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}